Lumateperone for pediatric bipolar depression
Treatments studied
Part of Mental health clinical trials.
This study tests a new medication called lumateperone for treating depression in children and teens with bipolar disorder. It aims to see if this drug can help improve mood and daily functioning.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child must be between 10 and 17 years old.
- They must have a diagnosis of bipolar I or bipolar II disorder and be currently experiencing a depressive episode without psychosis.
- The current depressive episode must have lasted at least 4 weeks but less than 12 months.
- Your child should not have a primary diagnosis other than bipolar disorder (ADHD is okay if stable on meds for 30 days).
- They must not be at high risk for suicide or have had a manic episode in the last 30 days.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new medication called Lumateperone to see if it can reduce irritability in children and teens with autism. It's a 3-month trial that compares the study drug to a placebo (a pill with no active medicine) to find out if it helps with mood and behavior.
This study tests whether the drug lumateperone can help people with moderate to severe depression. If you join, you may receive the study drug or a placebo (a pill with no active medicine) to see if it improves your symptoms.
This trial tests a medication called lumateperone for children and teens with schizophrenia, bipolar disorder, or autism spectrum disorder. It aims to see if the medicine is safe and tolerable over time.
This study tests lumateperone, a new medication added to your current antidepressant, to help treat depression that hasn't improved with other treatments. It's designed for people age 60 and older who have tried at least two antidepressants without success.
This study tests if lumateperone, a medication for bipolar depression, can also help with weight and aging in people with obesity. You may qualify if you have bipolar I depression and a body mass index (BMI) over 30.
This study tests whether adding lumateperone to an antidepressant helps adults with major depressive disorder (MDD) who haven’t improved enough after trying at least two different antidepressants. It may help reduce depressive symptoms more than antidepressants alone.
Hear when a new Bipolar Depression trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.